Author:
Leupold J H,Yang H-S,Colburn N H,Asangani I,Post S,Allgayer H
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Reference61 articles.
1. Aguirre-Ghiso J, Liu D, Mignatti A, Kovalski K, Ossowski L . (2001). Urokinase receptor and fibronectin regulate the ERKMAPK to p38MAPK activity ratios that determine carcinoma cell proliferation or dormancy in vivo. Mol Biol Cell 12: 863–879.
2. Aguirre-Ghiso J, Estrada Y, Liu D, Ossowski L . (2003). ERKMAPK activity as a determinant of tumor growth and dormancy; regulation by p38SAPK. Cancer Res 63: 1684–1695.
3. Ahmed N, Oliva K, Wang Y, Quinn M, Rice G . (2003). Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR–b1 integrin complex in colon cancer cells. Br J Cancer 89: 374–384.
4. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM et al. (1987). A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239–3245.
5. Allgayer H, Wang H, Gallick GE, Crabtree A, Mazar A, Jones T et al. (1999a). Transcriptional induction of the urokinase receptor gene by a constitutively active Src. Requirement of an upstream motif (−152/−135) bound with Sp1. J Biol Chem 274: 18428–18437.
Cited by
146 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献